Oxycodone and Aspirin NDC 42806-061

NDC codes

FDA NDC Directory

Product NDC (as listed)42806-061Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42806-0061Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42806-061-01	42806006101	100 TABLET in 1 BOTTLE (42806-061-01)Marketed from Jun 30, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxycodone and Aspirin
Generic name (nonproprietary): oxycodone and aspirin
Active ingredients: Oxycodone hydrochloride — 4.8355 mg/1Aspirin — 325 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Epic Pharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040910
Marketing start: Jun 30, 2020
Listing expires: Dec 31, 2026
DEA schedule: CII
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)Full Opioid Agonists (Mechanism)
Identifiers: Product ID 42806-061_8cd322df-f304-482e-9ed5-a7afa26f5645SPL ID 8cd322df-f304-482e-9ed5-a7afa26f5645SPL set ID 3292a7c6-5ba3-4563-bc62-e43040634123RxCUI 848768UNII C1ENJ2TE6C, R16CO5Y76EUPC 0342806061015
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442806006101 followed by a unit qualifier and the quantity

Package 42806-0061-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 17, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Oxycodone and aspirin tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration (see WARNINGS ), reserve oxycodone and aspirin tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics) • Have not been tolerated, or are not expected to be tolerated, • Have not provided adequate analgesia, or are not expected to provide adequate analgesia Oxycodone and Aspirin tablets should not be used for an extended period of time un…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)